EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin

Zhijie Li, Hongmiao Wang, Nan Liu, Xiayuchen Lan, Ailing Xie, Ge Yuan, Bowen Li, Jiaxin Geng, Xiaodan Liu iD

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Zhijie Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Mitophagy, Cardiolipins, Diabetic Nephropathies, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "PRO•Run" Fund of the Nephrology Group of CEBM, The Educational Department of Liaoning Province, Department of Education of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipotoxicity plays a crucial role in the progression of diabetic kidney disease (DKD), yet the dynamic changes in renal lipid composition from diabetes to early‐stage DKD remain unclear. Free fatty acids, lactosylceramides and cardiolipin (CL) were identified as the most significantly altered lipids by quantitatively comparing targeted lipids in the renal cortex of the classic spontaneous diabetic db/db mice using high‐coverage targeted lipidomics. Further investigation into the causes and effects of decreased CL, which is a unique mitochondrial phospholipid, was conducted in mitochondria‐rich renal proximal tubular cells by using western blotting, real‐time PCR, immunohistochemistry and transmission electron microscopy. Reduced expression of cardiolipin synthase, a key enzyme in the CL synthesis pathway, and inhibition of CL‐related mitophagy were confirmed under high glucose conditions. In addition, the protective effect of CL‐targeted Szeto‐Schiller 31 in preserving mitophagy was demonstrated in both in vivo and in vitro studies. These findings provide new insights into the pathogenesis of early‐stage DKD from a lipid perspective and offer a theoretical basis for discovering new treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyCardiolipinsDiabetic NephropathiesLipid MetabolismKidneyAnimalsMiceMaleMitochondriaLipidomicsMice, Inbred C57BLDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

Szeto‐Schiller 31cardiolipincardiolipin synthasediabetic kidney diseasefree fatty acidlipidomicsmitophagyproximal tubulesphingolipid

Substanzen

Cardiolipins

Autor:innen und Institutionen

  • Department of Nephrology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • LipidALL Technologies Company Limited, Changzhou, Jiangsu, China.

ORCID-Profile: Xiaodan Liu

Förderung

  • "PRO•Run" Fund of the Nephrology Group of CEBM
  • The Educational Department of Liaoning Province
  • Department of Education of Liaoning Province

Zitieren

APA

Li, Z., Wang, H., Liu, N., Lan, X., Xie, A., Yuan, G., Li, B., Geng, J., & Liu, X. (2025). Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70419

Vancouver

Li Z, Wang H, Liu N, Lan X, Xie A, Yuan G, et al. Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70419

BibTeX
@article{Li2025,
  author = {Li, Zhijie and Wang, Hongmiao and Liu, Nan and Lan, Xiayuchen and Xie, Ailing and Yuan, Ge and Li, Bowen and Geng, Jiaxin and Liu, Xiaodan},
  title = {Renal Lipid Alterations From Diabetes to Early‐Stage Diabetic Kidney Disease and Mitophagy: Focus on Cardiolipin},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70419}
}
Kostenlos starten →